Andere Sprachen Biogen Inc. Xetra

Aktien

789617

US09062X1037

IDP

Realtime-Estimate Tradegate Andere Börsenplätze 17:46:56 22.05.2024			% 5 Tage	% 1. Jan.
207,2 ^EUR	-0,93 %		-3,77 %	-11,97 %

17:00	BIOGEN INC. : Wedbush gibt eine neutrale Bewertung ab	ZM
15:45	MÄRKTE USA/Börsen treten auf der Stelle - Fed-Protokoll und Nvidia im Fokus	DJ

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Biogen : accord pour l'acquisition de HI-Bio	15:33
Biogen rachète HI-Bio pour un montant pouvant atteindre 1,8 milliard de dollars	14:55
Biogen to Acquire Human Immunology Biosciences for up to $1.8 Billion	14:18
Biogen to buy Human Immunology Biosciences in up to $1.8 billion deal	13:37
Biogen Bolsters Late-Stage Pipeline, Expands Immunology Portfolio with Agreement to Acquire Human Immunology Biosciences	13:30
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading	16.05.
Sector Update: Health Care Stocks Ease Thursday Afternoon	16.05.
US Equity Indexes Trade Mixed as Investors Weigh Macro Data; Dow Touches Record High	16.05.
Sector Update: Health Care	16.05.
Dow Touches 40,000 Mark for First Time as Macroeconomic Data Signals Economic Weakness	16.05.
Ionis Pharmaceuticals Says Potential Angelman Syndrome Therapy Improves Symptoms in Phase 1/2a Study	16.05.
Stocks in motion: Walmart, Chubb, Deere...	16.05.
Eisai Initiates Rolling Biologics License Application to US FDA for LEQEMBI for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer's Disease Under the Fast Track Status	16.05.
Sector Update: Health Care Stocks Steady Premarket Thursday	16.05.
Biogen, Ionis to Cease BIIB105 ALS Investigational Drug Development Following Phase 1/2 Trial Results	16.05.
Ionis and Biogen Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	16.05.
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	16.05.
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis	16.05.
Valores destacados al cierre del mercado norteamericano	16.05.
Sector Update: Health Care Stocks Advance Late Wednesday Afternoon	15.05.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Biogen Inc. Xetra

Aktien

789617

US09062X1037

IDP

Andere Sprachen

Filter